Article · 4 May 2026
ArticlePublished 28 Aug 2023
Therapeutic Efficacy of Atorvastatin and Aspirin on Inflammatory Factors in Cerebral Venous Thrombosis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This paper primarily discusses about the influence of atorvastatin plus aspirin on efficacy and inflammatory factors in patients with cerebral venous thrombosis. The study participants comprised 240 cerebral venous thrombosis patients selected between January 2020 and June 2022 who were grouped as a conventional group (n=107) treated with aspirin and a research group (n=133) treated by atorvastatin+aspirin based on the therapy they received. Statistical and comparative analysis were made regarding the curative efficacy, adverse events (gastrointestinal discomfort, nausea, vomiting and dizziness), inflammatory factors (interleukin-6, tumor necrosis factor-alpha, procalcitonin, high-sensitivity C-reactive protein), platelet parameters (hematocrit, platelet adhesion rate), nerve function injury (National Institute of Health Stroke Scale) and activities of daily living. Based on the analysis results, the research group had a higher overall response rate, a lower complication rate and reduced inflammatory factors, platelet parameters and National Institute of Health Stroke Scale scores than the conventional group, as well as notably higher post-treatment activities of daily living, with statistical significance. From the above, it can be concluded that atorvastatin+aspirin is significantly effective in treating cerebral venous thrombosis, validly inhibiting inflammation, improving platelet parameters, alleviating neurological impairment and enhancing patients’ activities of daily living.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hu Shen”
- BylineArticles whose byline prints “Hui Qiu”
- BylineArticles whose byline prints “Baoming He”